AI's Real Gift to Science

Claude’s headline-grabbing enzyme claim may overstate its novelty. But its true value lies in accelerating data analysis—a quiet revolution with real potential.

</div>

The boldest claim—and why it falters

Anthropic claimed that Claude discovered a novel enzyme system resembling CRISPR in under 24 hours, positioning it as a breakthrough with revolutionary promise . But experts pushed back. Fyodor Urnov, a genome-editing pioneer, said “the jury is out” on whether the finding even qualifies as an enzyme . A team at the University of Copenhagen said they had already been aware of the same system, raising questions about novelty . This undercuts the headline; the finding may not be new, and Anthropic acknowledged uncertainty.

Claude’s real capability: scaling scientific attention

Where the claim holds up is in speed. Claude reportedly deployed 950 bots to analyze nearly two billion DNA entries, a scale humans could not match . Bo Wang, assistant professor at University of Toronto, argues AI’s biggest impact is “scaling scientific attention,” surfacing outliers for human follow-up . This aligns with the bottleneck identified by a 2012 bioinformatics committee: data analysis—not production—is now the constraint .